Science Explorer Interactive view Map
Hospital / health system · Chisinau · Moldova

Institutul Oncologic din Republica Moldova

World rank, all time
#42,666
of 42,892
Rank in Moldova
#24
of 24
Research works
128
▲ 28% vs 2013–17
Citations
158
1.2 per fractional work
Top-10% rate
1.1%
record average 16.5%
Open access
52%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.10× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.03× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.93× its world share, 1 worksImmunology and Micro…Chemistry: 0.05× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEnvironmental Science: 0.40× its world share, 1 worksEnvironmental SciencePhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyDentistry: 0.83× its world share, 0 worksDentistryHealth Professions: 0.98× its world share, 1 worksHealth ProfessionsMedicine: 3.95× its world share, 32 worksMedicineVeterinary: 3.93× its world share, 0 worksVeterinaryArts and Humanities: 0.28× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.75× its world share, 1 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologySocial Sciences: 0.17× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Who are the top researchers at Institutul Oncologic din Republica Moldova?

Ranked on the composite score, I Spînu lead among researchers whose main affiliation is Institutul Oncologic din Republica Moldova.

  1. 1 I Spînu Moldova · #1,237,483 worldwide 0 citations · 19 works
All ranked researchers at Institutul Oncologic din Republica Moldova

Which keywords describe research at Institutul Oncologic din Republica Moldova?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Chemotherapy, Epidemiology, Classification, Gene Expression Profiling, Molecular Profiling and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 2.9×22 topics
  2. Prognostic Factors4▲ 19×6 topics
  3. Rituximab4▲ 56×3 topics
  4. Chemotherapy3▲ 10×11 topics
  5. Classification3▲ 15×2 topics
  6. Gene Expression Profiling2▲ 73×2 topics
  7. Molecular Profiling2▲ 60×2 topics
  8. Lymphoma2▲ 35×2 topics
  9. PET Imaging2▲ 32×2 topics
  10. Prognostic Scoring System2▲ 141×2 topics
  11. Climate Change2▲ 1.93×3 topics
  12. Genetics2▲ 7.5×3 topics
  13. Cancer2▲ 3.8×9 topics
  14. Genetic Pathogenesis2▲ 96×1 topic
  15. Hodgkin's Lymphoma2▲ 96×1 topic
  16. Inflammation2▲ 2.3×8 topics
  17. JAK2 Mutation2▲ 208×1 topic
  18. Myelofibrosis2▲ 208×1 topic
  19. BCR-ABL2▲ 148×1 topic
  20. Grapevine2▲ 100×2 topics
  21. Imatinib2▲ 148×1 topic
  22. Metastasis2▲ 12×4 topics
  23. Mutation2▲ 22×3 topics
  24. Biomarkers2▲ 5.7×4 topics
  25. Anthocyanins2▲ 53×1 topic
  26. Tumor Microenvironment2▲ 8.1×3 topics
  27. Wine Quality2▲ 103×1 topic
  28. Clinical Characteristics1▲ 26×2 topics
  29. Clinical Trials1▲ 5.0×3 topics
  30. Acute Lymphoblastic Leukemia1▲ 96×1 topic
  31. Cancer Incidence1▲ 22×3 topics
  32. Childhood Cancer1▲ 96×1 topic
  33. Chronic Lymphocytic Leukemia1▲ 70×1 topic
  34. Complications1▲ 6.2×4 topics
  35. Genomic Aberrations1▲ 70×1 topic
  36. Genomic Analysis1▲ 12×2 topics
  37. Minimal Residual Disease1▲ 47×2 topics
  38. Cancer Survivorship1▲ 38×2 topics
  39. Surgery1▲ 8.0×4 topics
  40. Cytoreductive Surgery1▲ 38×1 topic

Which research topics does Institutul Oncologic din Republica Moldova publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments and Horticultural and Viticultural Research.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  2. 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  3. 3 Chronic Myeloid Leukemia Treatments Hematology 2 works
  4. 4 Horticultural and Viticultural Research Plant Science 2 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
  6. 6 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
  7. 7 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 1 works
  8. 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
  9. 9 Multiple and Secondary Primary Cancers Epidemiology 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.9%not open48.1%

World: 28% of research is openly available.

with international co-authors14.3%domestic only85.7%

World: 19% is written across borders.

How has Institutul Oncologic din Republica Moldova's research output changed?

Output in 2018–2022 was 28% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Chisinau

All research institutions in Chisinau

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.